天津医药
天津醫藥
천진의약
TIANJIN MEDICAL JOURNAL
2014年
9期
949-952
,共4页
新生血管化,病理性%内皮细胞%综述%血管生成%vasohibin
新生血管化,病理性%內皮細胞%綜述%血管生成%vasohibin
신생혈관화,병이성%내피세포%종술%혈관생성%vasohibin
neovascularization,pathologic%endothelial cells%review%angiogenesis%vasohibin
血管生成依赖于血管生成刺激因子和抑制因子之间的平衡。Vasohibin家族作为新近发现的血管生成调节因子,参与多种病理生理过程。其中Vasohibin-1是迄今为止发现的唯一以负反馈为作用机制调节血管生成的因子,可抑制血管生成;而Vasohibin-2促进血管生成,表达于肿瘤细胞和单核细胞;研究还发现了一个小分子的Vasohibin结合蛋白,其存在于内皮细胞,可与Vasohibin-1和Vasohibin-2结合,与Vasohibin-1结合时,增强抗血管生成的活性,扮演分泌伴侣作用。本文就Vasohibin家族成员的结构特点、生物活性及在抑制病理性血管生成中的作用作一综述。
血管生成依賴于血管生成刺激因子和抑製因子之間的平衡。Vasohibin傢族作為新近髮現的血管生成調節因子,參與多種病理生理過程。其中Vasohibin-1是迄今為止髮現的唯一以負反饋為作用機製調節血管生成的因子,可抑製血管生成;而Vasohibin-2促進血管生成,錶達于腫瘤細胞和單覈細胞;研究還髮現瞭一箇小分子的Vasohibin結閤蛋白,其存在于內皮細胞,可與Vasohibin-1和Vasohibin-2結閤,與Vasohibin-1結閤時,增彊抗血管生成的活性,扮縯分泌伴侶作用。本文就Vasohibin傢族成員的結構特點、生物活性及在抑製病理性血管生成中的作用作一綜述。
혈관생성의뢰우혈관생성자격인자화억제인자지간적평형。Vasohibin가족작위신근발현적혈관생성조절인자,삼여다충병리생리과정。기중Vasohibin-1시흘금위지발현적유일이부반궤위작용궤제조절혈관생성적인자,가억제혈관생성;이Vasohibin-2촉진혈관생성,표체우종류세포화단핵세포;연구환발현료일개소분자적Vasohibin결합단백,기존재우내피세포,가여Vasohibin-1화Vasohibin-2결합,여Vasohibin-1결합시,증강항혈관생성적활성,분연분비반려작용。본문취Vasohibin가족성원적결구특점、생물활성급재억제병이성혈관생성중적작용작일종술。
Angiogenesis is regulated by the local balance between angiogenesis stimulators and inhibitors. Vasohibin family as a novel regulator of angiogenesis involves in the process of various pathophysiology. Vasohibin-1 is the only factor that regulates angiogenesis by means of negative feedback as the mechanism of action. It is expressed in ECs to terminate an-giogenesis. Subsequently one gene homologous to vasohibin-1 was found and designated as vasohibin-2, which is expressed in infiltrating MNCs or cancer cells to stimulate angiogenesis. Furthermore, one binding protein to vasohibin-1 and vasohib-in-2 has been discovered and renamed as small vasohibin-binding protein (SVBP). The analysis of the function of SVBP has revealed that SVBP binds to vasohibin-1 within cells, makes a heterodimer with vasohibin-1 and facilitates the secretion of vasohibin-1. This article reviews the construction features and biological activities of vasohibin family members and their ef-fects of inhibiting pathology angiogenesis.